Autolus Therapeutics PLC
NASDAQ:AUTL

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
NASDAQ:AUTL
Watchlist
Price: 2.25 USD 3.21% Market Closed
Market Cap: 598.8m USD
Have any thoughts about
Autolus Therapeutics PLC?
Write Note

Autolus Therapeutics PLC
Investor Relations

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. The firm is focused on developing programmed T cell therapies for the treatment of cancer. The firm has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. Its lead clinical programs include AUTO1 (obecabtagene autoleucel, Obe-Cel), AUTO4, and AUTO6 / AUTO6NG. Obe-cel is a CD19 CAR T cell investigational therapy designed to overcome limitations in clinical activity and safety. Obe-cel reduces toxicity and is less prone to T cell exhaustion, which could improve persistence and the ability of programmed T cells to engage in serial killing of target cancer cells. AUTO4 is a T cell therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1. AUTO6 / AUTO6NG is a T cell therapy targeting GD2 in development for the treatment of neuroblastoma. Its other clinical programs include AUTO5, AUTO7, and AUTO8.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Christian Martin Itin Ph.D.
CEO & Director
No Bio Available
Dr. Martin Pule M.D., MBBS
Founder, Senior VP & Chief Scientific Officer
No Bio Available
Mr. Robert F. Dolski
Senior VP & CFO
No Bio Available
Mr. Christopher Vann
Senior VP & COO
No Bio Available
Mr. David Brochu
Senior VP & Chief Technical Officer
No Bio Available
Mr. Alexander Swan
Senior VP & Chief Human Resources Officer
No Bio Available
Mr. Brent Rice
Senior VP, Chief Commercial Officer & Site Head of US
No Bio Available
Ms. Olivia Manser
Director of Investor Relations
No Bio Available
Mr. Alex Driggs
Senior VP of Legal Affairs & General Counsel and Secretary
No Bio Available
Dr. Chris Williams
Senior VP & Chief Business Development Officer
No Bio Available

Contacts

Address
London
The Mediaworks, 191 Wood Lane
Contacts
+442038296230.0
www.autolus.com